Clinical Research Directory
Browse clinical research sites, groups, and studies.
REal World MAIA UK OutcomEs
Sponsor: The Royal Wolverhampton Hospitals NHS Trust
Summary
This study will describe the use of triplet therapy with daratumumab, lenalidomide and dexamethasone (DRd) in the treatment of for transplant ineligible (TIE) untreated myeloma outside of clinical trials and assess the associated clinical outcomes.
Official title: A Retrospective Study of Clinical Outcomes in Newly Diagnosed, Transplant Ineligible Multiple Myeloma Patients Treated With Daratumumab, Lenalidomide and Dexamethasone (DRd) Outside of Clinical Trials in the UK
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
300
Start Date
2026-07
Completion Date
2028-07
Last Updated
2026-04-16
Healthy Volunteers
Not specified
Conditions
Locations (1)
The Royal Wolverhampton NHS Trust
Wolverhampton, United Kingdom